LON:ABDX Abingdon Health (ABDX) Share Price, News & Analysis GBX 5.90 +0.05 (+0.77%) As of 09/29/2025 11:56 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock About Abingdon Health Stock (LON:ABDX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Abingdon Health alerts:Sign Up Key Stats Today's Range 5.70▼ 650-Day Range 5.37▼ 6.8052-Week Range 5.10▼ 9.50Volume105,123 shsAverage Volume141,353 shsMarket Capitalization£11.42 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests. The Company offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. This ability has a significant role to play in improving life across the world. To support this aim Abingdon Health has also developed AppDx®, a customisable image capturing technology and algorithm that transforms a smartphone into a self-sufficient, standalone lateral-flow reader. Founded in 2008, Abingdon Health is headquartered in York, England. Read More Receive ABDX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abingdon Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ABDX Stock News HeadlinesAbingdon Health (LON:ABDX) Trading 3.4% Higher - Here's What HappenedSeptember 26, 2025 | americanbankingnews.comAbingdon Health grants stock options to key personnelMay 4, 2025 | uk.investing.comForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He says a 4-nanometer device that's 80 MILLION times more powerful than the chip he gave Reagan is now being made in America for the first time. And he's identified 3 companies that control this technology. | Banyan Hill Publishing (Ad)Medical diagnostics company based in United Kingdom opens Madison officeApril 10, 2025 | msn.comAbingdon Health First Half 2025 Earnings: UK£0.007 loss per share (vs UK£0.004 loss in 1H 2024)March 27, 2025 | uk.finance.yahoo.comWhen Will Abingdon Health Plc (LON:ABDX) Breakeven?March 23, 2025 | finance.yahoo.comBallad Health announces creation of Quillen Center for Urological Services in AbingdonJanuary 22, 2025 | msn.comHMG Urgent Care opens in AbingdonNovember 21, 2024 | msn.comSee More Headlines ABDX Stock Analysis - Frequently Asked Questions How have ABDX shares performed this year? Abingdon Health's stock was trading at GBX 7.92 at the beginning of the year. Since then, ABDX shares have decreased by 25.5% and is now trading at GBX 5.90. How were Abingdon Health's earnings last quarter? Abingdon Health Plc (LON:ABDX) issued its quarterly earnings results on Monday, March, 24th. The company reported ($0.53) earnings per share for the quarter. Abingdon Health had a negative net margin of 20.72% and a negative trailing twelve-month return on equity of 62.56%. How do I buy shares of Abingdon Health? Shares of ABDX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Abingdon Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Abingdon Health investors own include 4D pharma (DDDD), genedrive (GDR), Novacyt (NCYT), Rolls-Royce Holdings plc (RR.L), Tullow Oil (TLW), Active Energy Group (AEG) and B&M European Value Retail (BME). Company Calendar Last Earnings3/24/2025Today9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolLON:ABDX CIKN/A Webwww.abingdonhealth.com Phone44 19 0440 6082FaxN/AEmployees84Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£796.37 thousand Net Margins-20.72% Pretax MarginN/A Return on Equity-62.56% Return on Assets-17.93% Debt Debt-to-Equity Ratio46.64 Current Ratio1.95 Quick Ratio1.96 Sales & Book Value Annual Sales£6.82 million Price / Sales1.68 Cash FlowGBX 2.62 per share Price / Cash Flow2.25 Book ValueGBX 0.73 per share Price / Book8.11Miscellaneous Outstanding Shares193,631,000Free FloatN/AMarket Cap£11.42 million OptionableNot Optionable Beta0.13 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (LON:ABDX) was last updated on 9/30/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredDefense Billions Flow Into Critical Minerals — Here’s Why Gold’s KeyWhat do missile defense systems and gold miners have in common? More than most investors realize. The Unite...The Tomorrow Investor | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abingdon Health Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Abingdon Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.